Carboplatin plus taxol is an effective third-line regimen in recurrent undifferentiated nasopharyngeal carcinoma

Tumori

Volumn 88, Issue 4, 2002, Pages 273-276

  Airoldi, Mario ^a   Pedani, Fulvia ^a   Marchionatti, Sara ^a   Gabriele, Anna Maria ^a   Succo, Giovanni ^a   Gabriele, Pietro ^a   Bumma, Cesare ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Carboplatin; Chemotherapy; Nasopharyngeal cancer; Taxol

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CIMETIDINE; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; EPIRUBICIN; FLUOROURACIL; HEMOPOIETIC GROWTH FACTOR; PACLITAXEL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NASOPHARYNX CARCINOMA; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; RECURRENT CANCER; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNDIFFERENTIATED CARCINOMA;

EID: 0036658599     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800405     Document Type: Article

References (28)

1. Orecchia R, Airoldi M, Sola B, Ragona R, Bussi M, Bongioannini G, Cavalot A, Valente G: Results of chemotherapy plus external re-irradiation in the treatment of locally advanced recurrences of nasopharyngeal carcinoma. Oral Oncol Eur J Cancer, 28B: 109-111, 1992.
2. Wang CC: Re-irradiation of recurrent nasopharyngeal carcinoma. Treatment techniques and results. Int J Radiat Oncol Biol Phys, 13: 953-956, 1987.
3. Boussen H, Cvitkovic E, Wendling JL, Azli N, Bachouchi M, Mahjoubi R, Kalifa C, Wibault P, Schwaab G, Armand JP: Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil. J Clin Oncol, 9: 1675-1681, 1991.
4. Abs L, Mahjoubi R, Bachouchi M, Azli N, Fandi K, Armand JP, Cvitkovic E: BEC (bleomycin-epirubicin-cisplatin) in metastatic/recurrent undifferentiated nasopharyngeal cancer. Eur J Cancer, 27: 148, 1991.
5. Airoldi M, Pedani F, Gabriele P, Giordano C, Cavalot A, Brando V: Combined chemotherapy for recurrent and metastatic nasopharyngeal carcinoma. J Chemother, 1: 272-276, 1989.
6. Choo R, Tannock I: Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. Cancer, 68: 2120-2124, 1991.
7. Decker DA, Drelichman A, Al-Sarraf M, Crissman J, Reed ML: Chemotherapy for nasopharyngeal carcinoma. A ten year experience. Cancer, 52: 602-605, 1993.
8. Marchini S, Licitra L, Grandi C, Travaglini R, Cascinelli N: Cisplatin and fluorouracil in recurrent and/or disseminated nasopharyngeal carcinoma. Proc Am Soc Clin Oncol, 10: 202, 1991.
9. Dugan M, Shiu W, Choy D, Tan B, Vootiprux V, Villalon A, Chen KY, Hsu MM, Prasad U, Ngai A, Dy E, Neal J, Reisman A: A multicenter trial of novantrone in advanced nasopharyngeal carcinoma in the Southeast Asia. Proc Am Soc Clin Oncol, 10: 202, 1991.
10. Airoldi M, De Crescenzo A, Pedani F, Marchionatti S, Gabriele AM, Succo G, Rosti G, Bumma C: Feasibility and long-term results of autologous PBSC transplantation in recurrent undifferentiated nasopharyngeal carcinoma. Head Neck, 23: 799-803, 2001.
11. Fandi A, Taamma A, Azli N, Bachouchi M, Yanes B, Armand JP, Cvitkovic E: Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type. Head Neck, 19: 41-47, 1997.
12. Chua DTT, Kwong DLW, Sham JST, Au GKH, Choy D: A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy. Eur J Cancer, 36: 736-741, 2000.
13. nd line chemotherapy in refractory/relapsed nasopharyngeal carcinoma patients. Ann Oncol, 11: 83, 2000.
14. Yeo W, Leung WT, Chan ATC, Teo PML, Johnson PJ: Cisplatin and adriamycin combination chemotherapy in locoregional recurrent and metastatic nasopharyngeal carcinoma. Proc Am Soc Clin Oncol, 15: 319, 1996.
15. Cognetti F, Schomagel J, Wildiers J, De Mulder P, Verweij J, Vermorken JB, Kirkpatrick A, Lefebvre JL: Phase II trial of epirubicin and cisplatin in advanced undifferentiated nasopharyngeal carcinoma. Eur J Cancer, 27: 148, 1991.
16. Oliveira J, Martins A, Lage P, Gil N, Magalhaes M, Araujo F, Torrinha F, Olias J, Fernandes A, Santiago N: Cisplatin and high dose epirubicin in non queratinizing epidermoid carcinoma of the nasopharynx. Proc Am Soc Clin Oncol, 15: 313, 1996.
17. Cvitkovic E, Mahjoubi R, Lianes P, Armand JP, Azli N, Wibault P: 5-fluorouracil, mitomycin, epirubicin, cisplatin in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma. Preliminary activity/toxicity report. Proc Am Soc Clin Oncol, 10: 200, 1991.
18. Chi KH, Chang YC, Chan WK, Liu JM, Law CK, Lo SS, Shu CH, Yen SH, Whang-Peng J, Chen KY: A phase II study of carboplatin in nasopharyngeal carcinoma. Oncology, 54: 203-207, 1997.
19. Shiu W, Tsao SY, Tsai HC: Efficacy of cisplatinum as single agent in nasopharyngeal carcinoma. Chin J Clin Oncol, 16: 259-260, 1989.
20. Leung WT, Shiu W, Tao M, Teo P, Leung SF, Choi PHK: Phase II study of carboplatin and 5-FU combination in treatment of advanced nasopharyngeal carcinoma. Proc Am Soc Clin Oncol, 10: 199, 1991.
21. Lai GM, Ng KT: High dose 5-fluorouracil plus cis-platinum in treatment of advanced nasopharyngeal carcinoma. Proc Am Soc Clin Oncol, 5: 143, 1986.
22. Au E, Ang PT, Chua EJ: Paclitaxel in metastatic nasopharyngeal cancer. Proc Am Soc Clin Oncol, 15: 322, 1996.
23. Chi KH, Chan WK, Chao Y, Wang CS, Chen SY, Shu CH, Yen SH, Shian CY, Liang MZ, Chen KY: Phase II study of paclitaxel therapy for chemotherapy-naive advanced nasopharyngeal carcinoma. Proc Am Soc Clin Oncol, 16: 398, 1997.
24. Chen MC, Wang CC, Liu JM, Chen LT, Chow JM, Hsu C, Hsu CH, Lu YS, Su LY, Yu YC, Huang HP, Whang-Peng J: Paclitaxel 96-hour intravenous infusion in treating metastatic nasopharyngeal carcinoma failed previous radiotherapy and chemotherapy. Proc Am Soc Clin Oncol, 16: 398, 1997.
25. Fountzilas G, Athanassiadis A, Samantas E, Skarlos D, Kalogera-Fountzilas A, Nikolaou A, Bacoyiannis H, Stathopoulos G, Kosmidis P, Daniilidis J: Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study. Semin Oncol, 24: 565-567, 1997.
26. Yeo W, Leung TWT, Chan AYC, Chiu SKW, Yu P, Mok TSK, Johnson PJ: A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma. Eur J Cancer, 34: 2027-2031, 1998.
27. Tan EH, Khoo KS, Au E: Phase II trial of paclitaxel and carboplatin in patients with metastatic undifferentiated nasopharyngeal carcinoma. Proc Am Soc Clin Oncol, 17: 383, 1998.
28. Ciuleanu TE, Ciuleanu E, Todoir N, Ghilezan N: Paclitaxel and carboplatin salvage chemotherapy in relapsed nasopharyngeal carcinoma. Ann Oncol, 9: 76, 1998.